Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Medicine > 2025 Vol. 3 > No. 1 > 100107
Next Article Previous Article
COMMENTARY   Open Access     Cite

From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development

  • 1.

    Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China

More Information
  • Corresponding author: xiaogangwang@smu.edu.cn
  • Received Date:  September 29, 2024
    Accepted Date:  December 10, 2024
    Published Online:  December 18, 2024
The Innovation Medicine  3(1),  https://doi.org/10.59717/j.xinn-med.2024.100107  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] McPherson M., Hobson A., Hernandez A. J., et al. (2024). An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases. Sci. Transl. Med. 16:eadd8936. DOI:10.1126/scitranslmed.add8936

    View in Article CrossRef Google Scholar

    [2] Shen L., Sun X., Chen Z., et al. (2024). ADCdb: The database of antibody-drug conjugates. Nucleic Acids Res. 52:D1097−D1109. DOI:10.1093/nar/gkad831

    View in Article CrossRef Google Scholar

    [3] Chen L., Li B., Chen Y., et al. (2024). ADCNet: A unified framework for predicting the activity of antibody-drug conjugates. arXiv:2401.09176. DOI:10.48550/arXiv.2401.09176.

    View in Article Google Scholar

    [4] Abramson J., Adler J., Dunger J., et al. (2024). Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630:493−500. DOI:10.1038/s41586-024-07487-w

    View in Article CrossRef Google Scholar Scopus

    [5] Ren F., Aliper A., Chen J., et al. (2024). A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat. Biotechnol.:Online ahead of print. DOI:10.1038/s41587-024-02143-0

    View in Article Google Scholar

    • Cited by

  • Cite this article:

    Liu M. and Wang X. (2025). From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development. The Innovation Medicine 3:100107. https://doi.org/10.59717/j.xinn-med.2024.100107
    Liu M. and Wang X. (2025). From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development. The Innovation Medicine 3:100107. https://doi.org/10.59717/j.xinn-med.2024.100107

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(6389) PDF downloads(4974)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.